BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12622009)

  • 1. [Acute renal failure following treatment with intravenously administered immunoglobulins].
    van Zanten AR; Beekhuyzen M; van der Meer YG; de Gooijer A; Feith GW
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):307-10. PubMed ID: 12622009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute renal failure resulting from intravenous immunoglobulin therapy.
    Wajanaponsan N; Cheng SF
    Hawaii Med J; 2004 Sep; 63(9):266-7. PubMed ID: 15540524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal failure and intravenous immune globulin: occurs with sucrose-stabilized, but not with D-sorbitol-stabilized, formulation.
    Chapman SA; Gilkerson KL; Davin TD; Pritzker MR
    Ann Pharmacother; 2004 Dec; 38(12):2059-67. PubMed ID: 15536143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure after administration of intravenous immunoglobulin: review of the literature and case report.
    Winward DB; Brophy MT
    Pharmacotherapy; 1995; 15(6):765-72. PubMed ID: 8602385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reemergence of sucrose nephropathy: acute renal failure caused by high-dose intravenous immune globulin therapy.
    Zhang R; Szerlip HM
    South Med J; 2000 Sep; 93(9):901-4. PubMed ID: 11005352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute kidney failure secondary to intravenous immunoglobulin administration. 4 cases and review of the literature].
    Decocq G; de Cagny B; Andréjak M; Desablens B
    Therapie; 1996; 51(5):516-26. PubMed ID: 9138386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
    Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
    Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin induced-nephropathy: a complication of IVIG therapy.
    Ahsan N
    J Nephrol; 1998; 11(3):157-61. PubMed ID: 9650125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: acute renal failure after administering intravenous immunoglobulin.
    Graumann A; Zawada ET
    Postgrad Med; 2010 Mar; 122(2):142-7. PubMed ID: 20203465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
    Chamouni P; Tamion F; Gueit I; Girault C; Lenain P; Varin R; Czernichow P
    Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia.
    Subtirelu MM; Flynn JT; Schechner RS; Pullman JM; Feuerstein D; Del Rio M
    Pediatr Transplant; 2005 Dec; 9(6):801-4. PubMed ID: 16269055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobinuria and acute kidney injury requiring hemodialysis following intravenous immunoglobulin infusion.
    Welles CC; Tambra S; Lafayette RA
    Am J Kidney Dis; 2010 Jan; 55(1):148-51. PubMed ID: 19628320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of intravenous immunoglobulin (IVIG) therapy.
    Katz U; Achiron A; Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome.
    Koichihara R; Hamano S; Yamashita S; Tanaka M
    Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
    Barsheshet A; Marai I; Appel S; Zimlichman E
    Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal failure after intravenous immunoglobulin therapy.
    Pasatiempo AM; Kroser JA; Rudnick M; Hoffman BI
    J Rheumatol; 1994 Feb; 21(2):347-9. PubMed ID: 8182648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.
    Lozeron P; Not A; Theaudin M; Denier C; Masnou P; Sarov M; Adam C; Cauquil C; Adams D
    Muscle Nerve; 2016 May; 53(5):683-9. PubMed ID: 26467654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous gammglobulin-associated acute renal failure.
    Gupta N; Ahmed I; Nissel-Horowitz S; Patel D; Mehrotra B
    Am J Hematol; 2001 Feb; 66(2):151-2. PubMed ID: 11421298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Practical comments on the use of immunoglobulins].
    Lewandowicz-Uszyńska A; Swierkot J
    Pol Merkur Lekarski; 2011 Jun; 30(180):448-51. PubMed ID: 21751557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotoxicity of intravenous immunoglobulin in the setting of liver transplantation or HBV-related cirrhosis: an undervalued topic.
    Angeli P; Scaglione F
    Minerva Gastroenterol Dietol; 2008 Sep; 54(3):259-75. PubMed ID: 18614975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.